Correlation Between Oncotelic Therapeutics and BiOasis Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncotelic Therapeutics and BiOasis Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncotelic Therapeutics and BiOasis Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncotelic Therapeutics and biOasis Technologies, you can compare the effects of market volatilities on Oncotelic Therapeutics and BiOasis Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncotelic Therapeutics with a short position of BiOasis Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncotelic Therapeutics and BiOasis Technologies.

Diversification Opportunities for Oncotelic Therapeutics and BiOasis Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Oncotelic and BiOasis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncotelic Therapeutics and biOasis Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on biOasis Technologies and Oncotelic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncotelic Therapeutics are associated (or correlated) with BiOasis Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of biOasis Technologies has no effect on the direction of Oncotelic Therapeutics i.e., Oncotelic Therapeutics and BiOasis Technologies go up and down completely randomly.

Pair Corralation between Oncotelic Therapeutics and BiOasis Technologies

If you would invest  0.20  in biOasis Technologies on September 2, 2024 and sell it today you would lose (0.19) from holding biOasis Technologies or give up 95.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

Oncotelic Therapeutics  vs.  biOasis Technologies

 Performance 
       Timeline  
Oncotelic Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncotelic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Oncotelic Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
biOasis Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days biOasis Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BiOasis Technologies is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Oncotelic Therapeutics and BiOasis Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncotelic Therapeutics and BiOasis Technologies

The main advantage of trading using opposite Oncotelic Therapeutics and BiOasis Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncotelic Therapeutics position performs unexpectedly, BiOasis Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will offset losses from the drop in BiOasis Technologies' long position.
The idea behind Oncotelic Therapeutics and biOasis Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity